Leukaemia

• Health & Medicine

Three cancer drugs cleared for NHS funding in Scotland

Three cancer drugs have been approved for patients on the NHS in Scotland, including a drug for some patients with advanced liver cancer. Three cancer drugs have been approved for patients on the NHS in Scotland, including a drug for some patients with advanced liver cancer.

17 April 2019

• Health & Medicine

Leukaemia drug gets initial ‘no’ for NHS in England

Patients with a specific type of leukaemia will not have access to a new treatment after it failed to win provisional recommendation for NHS use in England. Patients with a specific type of leukaemia will not have access to a new treatment after it failed to win provisional recommendation for NHS use in England.

6 March 2019

• Health & Medicine

Double NHS decision for CAR T cell immunotherapy in Scotland

Two cancer immunotherapies have been reviewed for NHS use in Scotland as a treatment for some patients with aggressive blood cancer. Two cancer immunotherapies have been reviewed for NHS use in Scotland as a treatment for some patients with aggressive blood cancer.

13 February 2019

• Health & Medicine

First patient receives CAR T cell therapy on NHS

An 11-year-old boy became the first NHS patient to receive a personalised blood cancer immunotherapy on the NHS. An 11-year-old boy became the first NHS patient to receive a personalised blood cancer immunotherapy on the NHS.

31 January 2019

• Personal Stories

Chelsea legend Gianfranco Zola surprises Blues fan and cancer survivor

Gianfranco Zola gave eighteen-year-old Ed Garside the surprise of his life in a special meeting organised by Stand Up To Cancer’s official partner, Hyundai Moto Gianfranco Zola gave eighteen-year-old Ed Garside the surprise of his life in a special meeting organised by Stand Up To Cancer’s official partner, Hyundai Moto

18 October 2018

• Health & Medicine

‘Cutting edge’ CAR T cell immunotherapy approved in England. But is the NHS ready?

With two complex CAR T immunotherapies now approved on the NHS in England, we look at how the health service has had to react to these exciting new treatments. With two complex CAR T immunotherapies now approved on the NHS in England, we look at how the health service has had to react to these exciting new treatments.

5 October 2018

• Personal Stories

Siblings affected by childhood cancer: ‘I’m so proud of what he’s done and how far he’s come’ – James’s story

James shares the story of his younger brother Max, who was diagnosed with chronic myeloid leukaemia, a type of blood cancer, in May 2003. James shares the story of his younger brother Max, who was diagnosed with chronic myeloid leukaemia, a type of blood cancer, in May 2003.

19 September 2018

• Health & Medicine

Making chemotherapy kinder for childhood leukaemia

Guest author, Dr Rosanna Jackson, outlines what scientists are doing to make treatment for one type of childhood leukaemia kinder. Guest author, Dr Rosanna Jackson, outlines what scientists are doing to make treatment for one type of childhood leukaemia kinder.

14 September 2018

• Health & Medicine

NHS England to fund personalised blood cancer immunotherapy

A cancer immunotherapy will be offered on the NHS in England to some children and young adults with leukaemia, NHS England announced today. A cancer immunotherapy will be offered on the NHS in England to some children and young adults with leukaemia, NHS England announced today.

5 September 2018

• Science & Technology
• Health & Medicine

Trial to test new treatment combination for children and adults with leukaemia

A clinical trial testing a new treatment combination in patients with leukaemia launches through the Combinations Alliance today. A clinical trial testing a new treatment combination in patients with leukaemia launches through the Combinations Alliance today.

30 May 2018

• Health & Medicine

Infection theory could explain cause of common childhood leukaemia, says scientist

A scientist has proposed a theory for how a common childhood cancer occurs, based on genetic faults and infections. A scientist has proposed a theory for how a common childhood cancer occurs, based on genetic faults and infections.

21 May 2018

• Science & Technology
• Health & Medicine

From cancer evolution to targeting faulty genetics – our new fellows

Find out the burning questions some of our researchers want to answer as they set up their own research teams for the first time. Find out the burning questions some of our researchers want to answer as they set up their own research teams for the first time.

31 October 2017